# Phadia Us Inc. (other, Portage, MI): 1 new FDA device listing, incl. extractable antinuclear antibody, antigen and control

**Score:** 50/100

| Field | Value |
|---|---|
| Establishment | Phadia Us Inc. |
| Owner / operator | Phadia Ab |
| Role | Other |
| Establishment types | Complaint File Establishment per 21 CFR 820.198 |
| Location | Portage, MI, US |
| New listings | 1 |
| Devices | Extractable Antinuclear Antibody, Antigen And Control |
| Product codes | LLL |
| Device classes | Class II |
| Medical specialties | Immunology |
| Brand names | EliA CTD 13 Screen |
| First new listing | 2026-07-01 |
| Latest new listing | 2026-07-01 |
| FDA registration number | 3004973408 |
| Registration expires | 2026-12-31 |

## Why this score
- Class II or III devices: QMS and regulatory demands.
- U.S. establishment.

Source: openFDA device registration and listing endpoint (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm). Last refreshed: 2026-11-04T21:52:36.524Z.
From the openFDA device registration and listing data, refreshed weekly. A listing shows a device an establishment says it makes or handles for the U.S. market; it is not FDA clearance or approval. Contact persons and street addresses are not stored. Verify in the FDA Establishment Registration and Device Listing database.